An exit beyond the pharmacophore model for 5-HT6R agents - a new strategy to gain dual 5-HT6/5-HT2A action for triazine derivatives with procognitive potential-Reference-Cited by-同舟云学术

An exit beyond the pharmacophore model for 5-HT6R agents - a new strategy to gain dual 5-HT6/5-HT2A action for triazine derivatives with procognitive potential

Published:2022-04 Issue: Volume:121 Page:105695
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Kucwaj-Brysz Katarzyna,Ali Wesam,Kurczab Rafał,Sudoł-Tałaj Sylwia,Wilczyńska-Zawal Natalia,Jastrzębska-Więsek Magdalena,Satała Grzegorz,Mordyl Barbara,Żesławska Ewa,Agnieszka-Olejarz-Maciej ,Czarnota Kinga,Latacz Gniewomir,Partyka Anna,Wesołowska Anna,Nitek Wojciech,Handzlik Jadwiga

Funder

Narodowe Centrum Nauki

Universität des Saarlandes

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference51 articles.

1. A. Burns, S. Iliffe, Alzheimer’s disease, BMJ (Online). 338 (2009) 467–471. https://doi.org/10.1136/bmj.b158.

2. Dual-acting agents for improving cognition and real-world function in Alzheimer’s disease: Focus on 5-HT6 and D3 receptors as hubs;Millan;Neuropharmacology,2020

3. Cognitive symptoms of Alzheimer’s disease: Clinical management and prevention;Joe;The BMJ.,2019

4. Classics in Chemical Neuroscience: Memantine;Alam;ACS Chem. Neurosci.,2017

5. Comparative Effectiveness and Safety of Cognitive Enhancers for Treating Alzheimer’s Disease: Systematic Review and Network Metaanalysis;Tricco;J. Am. Geriatr. Soc.,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selenium-containing compounds: a new hope for innovative treatments in Alzheimer’s disease and Parkinson’s disease;Drug Discovery Today;2024-08

2. Synthesis of Novel Triazine-Based Chalcones and 8,9-dihydro-7H-pyrimido[4,5-b][1,4]diazepines as Potential Leads in the Search of Anticancer, Antibacterial and Antifungal Agents;International Journal of Molecular Sciences;2024-03-23

3. First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT₆ Agents with a Beneficial Neuroprotective Profile against Alzheimer’s Disease;Journal of Medicinal Chemistry;2024-01-08

4. Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT6R ligands with noticeable action on AChE/BChE and chalcogen-dependent intrinsic activity in search for new class of drugs against Alzheimer's disease;European Journal of Medicinal Chemistry;2023-11

5. New Triazine Derivatives as Serotonin 5-HT6 Receptor Ligands;Molecules;2023-01-22